Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -41.69%-301.77K | -43.16%-74.87K | 32.48%-610.43K | 83.13%-18.3K | -80.53%-326.86K | 51.04%-212.98K | 70.86%-52.3K | -43.84%-904.06K | 24.62%-108.49K | -4.12%-181.06K |
| Net income from continuing operations | -549.67%-515.19K | -38.80%-159.89K | -311.66%-8.29M | -379.51%-7.92M | -185.33%-177.89K | 84.39%-79.3K | -81.98%-115.19K | -82.05%-2.01M | -164.69%-1.65M | 297.31%208.46K |
| Depreciation and amortization | -20.71%111 | -20.00%112 | -20.45%560 | -20.45%140 | -20.45%140 | -20.45%140 | -20.45%140 | -20.36%704 | -20.36%176 | -20.72%176 |
| Asset impairment expenditure | ---- | ---- | 2,282.79%8.83M | ---- | ---- | ---- | ---- | -41.75%370.4K | ---- | ---- |
| Unrealized gains and losses of investment securities | ---- | ---- | --20K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Remuneration paid in stock | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 260.49%493.13K | --306.13K | --0 |
| Deferred tax | ---- | ---- | -280.39%-1.05M | ---- | ---- | ---- | ---- | 425.99%581.97K | ---- | ---- |
| Other non cashItems | ---- | ---- | -9.93%-265.04K | --0 | 76.52%-81.41K | -275.55%-162.46K | 81.43%-21.17K | -312.61%-241.11K | 5,305.78%262.89K | -651.28%-346.75K |
| Change In working capital | 18.64%33.98K | 1.17%84.91K | 260.70%151.76K | 387.86%106.89K | -57.61%-67.7K | 140.34%28.64K | 3,618.70%83.92K | -61.82%-94.43K | -20.87%21.91K | -92.49%-42.96K |
| -Change in receivables | 213.94%11.23K | -95.81%2.34K | 268.78%28.07K | 692.91%43.21K | -839.32%-61.2K | 45.85%-9.86K | 9,508.42%55.92K | 50.02%-16.63K | 35.54%-7.29K | 136.12%8.28K |
| -Change in prepaid assets | -75.47%6.5K | --0 | 200.00%40K | --0 | 87.00%-6.5K | 232.50%26.5K | --20K | ---40K | --30K | ---50K |
| -Change in payables and accrued expense | 35.41%16.25K | 932.08%82.57K | 321.38%83.68K | 8,050.44%63.68K | --0 | 136.59%12K | 369.63%8K | -50.70%-37.8K | -102.05%-801 | -305.16%-1.23K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -41.69%-301.77K | -43.16%-74.87K | 32.48%-610.43K | 83.13%-18.3K | -80.53%-326.86K | 51.04%-212.98K | 70.86%-52.3K | -43.84%-904.06K | 24.62%-108.49K | -4.12%-181.06K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 66.86%-431.65K | 61.02%-232.27K | -0.08%-2.49M | 100.12%83 | 19.47%-591.68K | -39.23%-1.3M | 20.30%-595.85K | -297.67%-2.49M | 28.65%-70.08K | -155.64%-734.72K |
| Net PPE purchase and sale | 66.86%-431.65K | 61.02%-232.27K | -0.58%-2.49M | 104.11%2.88K | 19.47%-591.68K | -39.23%-1.3M | 18.65%-595.85K | -419.98%-2.47M | -370.88%-70.08K | -155.64%-734.72K |
| Net other investing changes | ---- | ---- | 81.58%-2.8K | ---- | ---- | ---- | ---- | 89.87%-15.2K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 66.86%-431.65K | 61.02%-232.27K | -0.08%-2.49M | 100.12%83 | 19.47%-591.68K | -39.23%-1.3M | 20.30%-595.85K | -297.67%-2.49M | 28.65%-70.08K | -155.64%-734.72K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -19.96%1.14M | 292.3K | -40.89%2.33M | 0 | 2,855.89%900.6K | -55.28%1.43M | 0 | 162.36%3.94M | -100.00%-1 | -92.31%30.47K |
| Net common stock issuance | -17.66%1.14M | --292.3K | -41.24%2.47M | -46.59%135.8K | 2,987.17%940.6K | -56.54%1.39M | --0 | 169.45%4.2M | 166.80%254.26K | -96.60%30.47K |
| Net other financing activities | ---- | ---- | 46.59%-135.8K | ---- | ---- | ---- | ---- | -363.99%-254.27K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -19.96%1.14M | --292.3K | -40.89%2.33M | --0 | 2,855.89%900.6K | -55.28%1.43M | --0 | 162.36%3.94M | -100.00%-1 | -92.31%30.47K |
| Net cash flow | ||||||||||
| Beginning cash position | -92.74%10.73K | -96.79%25.56K | 223.68%795.91K | -95.51%43.77K | -96.68%61.72K | 342.96%147.76K | 223.68%795.91K | 9,830.55%245.89K | 117.74%974.48K | 262.64%1.86M |
| Current changes in cash | 577.45%410.81K | 97.71%-14.83K | -240.06%-770.35K | 89.80%-18.21K | 97.97%-17.94K | -104.71%-86.04K | -204.96%-648.15K | 121.41%550.02K | 11.45%-178.57K | -1,255.58%-885.32K |
| End cash Position | 583.01%421.53K | -92.74%10.73K | -96.79%25.56K | -96.79%25.56K | -95.51%43.77K | -96.68%61.72K | 342.96%147.76K | 223.68%795.91K | 223.68%795.91K | 117.74%974.48K |
| Free cash from | 51.61%-733.42K | 52.61%-307.13K | 8.27%-3.1M | 91.37%-15.41K | -0.30%-918.54K | -10.58%-1.52M | 28.93%-648.15K | -205.86%-3.38M | -51.26%-178.57K | -98.52%-915.78K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.